Prosecution Insights
Last updated: May 29, 2026

Examiner: CHOWDHURY, IQBAL HOSSAIN

Tech Center 1600 • Art Units: 1652 1656

This examiner grants 74% of resolved cases

Performance Statistics

73.6%
Allow Rate
+13.6% vs TC avg
1,019
Total Applications
+57.8%
Interview Lift
1095
Avg Prosecution Days
Based on 991 resolved cases, 2023–2026

Rejection Statute Breakdown

0.8%
§101 Eligibility
19.3%
§102 Novelty
53.4%
§103 Obviousness
8.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17620786 METHOD FOR PREPARING A FERMENTATION MEDIUM Non-Final OA BASF SE
17786721 OPTIMIZED GENE THERAPY FOR TARGETING MUSCLE IN MUSCLE DISEASES Non-Final OA RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
19276049 BIO-BASED FEATHER KERATIN DECOMPOSITION METHOD AND SYSTEM Non-Final OA Imam Abdulrahman Bin Faisal University
18164118 METHOD FOR PREPARING A DNA NETWORK WITH CONTROLLED CRYSTAL STRUCTURE AND A METHOD FOR INJECTING DRUGS USING THE DNA NETWORK Non-Final OA UIF (University Industry Foundation), Yonsei University
17582418 Method of Modulating a Fibrotic Condition Final Rejection Agency For Science, Technology And Research
18072800 CRYPTIC METABOLITES AND METHOD FOR ACTIVATING SILENT BIOSYNTHETIC GENE CLUSTERS IN DIVERSE MICROORGANISMS Non-Final OA The Trustees of Princeton University
18666008 GENETIC MARKER AND/OR BIOMARKERS FOR TRAUMATIC BRAIN INJURY, AND ULTRASENSITIVE ASSAYS FOR BIOMARKERS OF TRAUMATIC BRAIN INJURY Non-Final OA Meso Scale Technologies, LLC.
18249231 LIPASE VARIANTS AND COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS Non-Final OA Novozymes A/S
18408520 ADVANCED GENOME EDITING Final Rejection MBP TITAN, LLC
17866026 AUTOMATED METHOD OF COMPUTATIONAL ENZYME IDENTIFICATION AND DESIGN Non-Final OA Arzeda Corp.
18268370 RECOMBINANT BACILLUS SP. MICROORGANISM AND METHOD FOR PRODUCING HUMAN MILK OLIGOSACCHARIDES USING SAME Non-Final OA SAMYANG CORPORATION
17754216 TREATMENT OF NEUROLOGICAL DISORDERS Non-Final OA IPSEN BIOPHARM LIMITED

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month